Useful resources for the 1 October 2020 Schedule changes
Extended catch-up programmes for Menactra and Zostavax
The catch-up programme for one dose of Menactra for individuals aged 13–25 years inclusively who are in their second, third or more years living in a boarding school hostel, tertiary education halls of residence, military barrack, or prison, has been EXTENDED TO 30 November 2021.
The catch-up programme for people aged 66–80 years inclusively been EXTENDED TO 31 December 2021.
Transition of ADT™ Booster to Boostrix®
PHARMAC has changed the earlier advice from the Ministry of Health regarding use of ADT Booster stock from 1 October.
- Providers with remaining stock are required to stop using ADT Booster and dispose of stock appropriately by returning unused ADT Booster to ProPharma for destruction.
- Providers will not be able to claim an Immunisation Subsidy claim for use of ADT Booster for the 45-years or 65-years booster vaccination after 1 October.
- There are no safety concerns regarding any ADT Booster vaccines doses administered from 1 October 2020.
- Delisting the vaccine is an administrative process associated with the change of funded vaccine to Boostrix.
Click on the link to read the Ministry of Health Immunisation Update 18 November 2020.
Useful Immunisation Handbook 2020 and Schedule change links
Immunisation Handbook 2020 on the Ministry of Health website, there are no printed copies available.
IMPORTANT NOTES regarding the Schedule Changes Guide:
- There has been a change to the advice in Table 1: Branding changes. ADT Booster was delisted on 1 October 2020 and has been replaced with Boostrix from 1 October. The second part of the advice, that the change from ADT Booster to Boostrix vaccine will occur when existing stock is used, no longer applies.
- There is an error in Table 3: 2020 Childhood schedule for those < 5 years old. The rotavirus vaccine schedule is two doses (6 weeks and 3 months). The rotavirus vaccine dose indicated at 5 months of age is an error.
This webinar covered:
- The new 12 month immunisation event
- PCV programme tweaks
- Vaccine brand changes
- New edition of the Immunisation Handbook
- National Measles Campaign
Provides an overview of the:
- National Immunisation Schedule from 1 October, including the addition of 12-months immunisation event, use of tetanus-containing vaccines from 7 years throughout adulthood, PCV vaccine schedules and PCV and HPV9 catch-up immunisation, and vaccine brand changes.
- Change in the preferred administration of MMR, varicella and zoster vaccines to the intramuscular (IM) route and selection of injection sites to administer the 12-months and 15-months immunisations, and a summary of changes to emergency equipment, adrenaline doses and resuscitation training requirements.
Provides background information for the changes to the Immunisation Schedule, preferred IM route for MMR, varicella and zoster vaccines, and emergency equipment, adrenaline doses and resuscitation training requirements.
Answers some anticipated questions around administration of multiple vaccines by the IM route at 12 months and 15 months of age, flexibility with administration of Schedule vaccines prior to their due date, and PMS (patient management system) related questions.
- UPDATE: On 20 November, Medtech advised providers that:
- The MedTech Evolution Version 3.0 PMS update will be released at 6pm on Friday 20 November as previously scheduled. However,
- The MedTech32 Version 23.0 PMS update has been delayed until 6pm on Friday 27 November.
- MedTech also advised that practices will now be able to directly upgrade to Version 23.0 from Version 22.19 without installing multiple updates. An Interbase Backup and Restore will still be required prior to starting the upgrade.
- Medtech previously provided pdf versions of information on query building in the interim:
National Immunisation Schedule from 1 October 2020 (A4 Schedule card)
Has the National Immunisation Schedule from 1 October 2020 on page 1 and a guide to funded vaccines for special groups on page 2.
Clarifies PCV10 vaccine schedules during the transition between a 3+1 dose schedule to a 2+1 dose schedule.
Three in a row for best protection (A4 poster)
Provides a visual guide for the administration of three vaccines by the IM route at 15 months of age.
This chart describes the key features and management of anaphylaxis in general practice, immunisation clinics and outreach immunisation settings and includes the recommended adrenaline doses for infants, children, adolescents and adults.
This chart describes the key features and management of anaphylaxis in pharmacies and includes the recommended adrenaline for adolescents aged 13 years or older and adults.
Updated Ministry of Health resources to support the Schedule changes are available from HealthEd (www.healthed.govt.nz)
For Well Child books not already carrying the current immunisation schedule effective from 1 October 2020.
Also available in Chinese simplified, Chinese traditional, Hindi, Samoan, Tongan